Jazz Pharmaceuticals (JAZZ) Other Gross PP&E Adjustments: 2010-2025
Historic Other Gross PP&E Adjustments for Jazz Pharmaceuticals (JAZZ) over the last 14 years, with Sep 2025 value amounting to $130.4 million.
- Jazz Pharmaceuticals' Other Gross PP&E Adjustments rose 38.74% to $130.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $159.8 million, marking a year-over-year increase of 2722.34%. This contributed to the annual value of $255.6 million for FY2024, which is 35.04% up from last year.
- Per Jazz Pharmaceuticals' latest filing, its Other Gross PP&E Adjustments stood at $130.4 million for Q3 2025, which was up 350.04% from -$52.1 million recorded in Q2 2025.
- Jazz Pharmaceuticals' 5-year Other Gross PP&E Adjustments high stood at $255.6 million for Q4 2024, and its period low was -$221.1 million during Q1 2024.
- Its 3-year average for Other Gross PP&E Adjustments is $6.4 million, with a median of -$27.8 million in 2023.
- As far as peak fluctuations go, Jazz Pharmaceuticals' Other Gross PP&E Adjustments surged by 1,522.75% in 2021, and later plummeted by 145.00% in 2024.
- Over the past 5 years, Jazz Pharmaceuticals' Other Gross PP&E Adjustments (Quarterly) stood at $218.3 million in 2021, then climbed by 0.57% to $219.6 million in 2022, then decreased by 13.81% to $189.3 million in 2023, then surged by 35.04% to $255.6 million in 2024, then skyrocketed by 38.74% to $130.4 million in 2025.
- Its Other Gross PP&E Adjustments was $130.4 million in Q3 2025, compared to -$52.1 million in Q2 2025 and -$174.0 million in Q1 2025.